The arrival of Retatrutide ZPHC, at a strength of 120mg, is creating considerable excitement within the healthcare community. This novel dual GIP and GLP-1 agonist medication seems to offer impressive improvements in weight shedding compared to existing therapies. Initial clinical studies have in